Is Alcohol Use Disorder Genetic?

Alcohol use disorder is approximately 50 percent heritable, and the best meta-analytic estimate puts heritability at 0.49 with a 95 percent confidence interval of 0.43 to 0.53 across 12 twin studies and 5 adoption studies.

Per NIAAA, genes make up about half of a person’s risk. That figure describes variation across a population rather than an individual’s probability, and the distinction changes what a family history means.

Key Takeaways

• Heritability sits at 0.49 in the best meta-analysis, with shared environment accounting for a further 0.10, and published estimates across the literature range from 40 to 70 percent.
• Heritability is a population statistic describing variance rather than an individual forecast.
• The best-characterized gene variants, ADH1B*2 and ALDH2*2, lower the risk of alcohol use disorder rather than raising it.
• One affected parent roughly doubles the odds, at 1.96 for maternal and 1.99 for paternal alcohol use disorder in a Danish cohort of 7,177 people.
• Polygenic risk scores explain roughly 2.5 to 3.5 percent of variance and function as no kind of clinical test.

What Does Heritability Actually Mean?

Heritability is the proportion of total variation in a trait across a population that traces to genetic differences within that population. Visscher, Hill and Wray describe heritability as an estimable, dimensionless population parameter, which means heritability answers a question about groups.

Two consequences follow, and both matter for anyone reading their own family history into the number. Heritability is not an individual risk percentage: a heritability of 0.49 means roughly half the observed variation in who develops alcohol use disorder tracks with genetic variation across a population, and says nothing about the split between genes and circumstance inside one person’s life.

Heritability is also specific to the population and the environment measured. Change the drinking environment and the figure moves, because the amount of variation available for genes to explain has changed. The Verhulst meta-analysis found no heterogeneity by study design, sex or assessment method, which is what makes its 0.49 unusually trustworthy, and the same analysis found shared environmental factors accounting for 0.10 of variance. Specific genes carry that heritability.

Which Genes Are Involved?

Two variants in the alcohol-metabolizing enzymes are the best understood, ADH1B*2 and ALDH2*2, and both variants lower the risk of alcohol use disorder. Both work by making the experience of drinking physically aversive rather than by altering reward.

Carriers of the ADH1B*2 variant metabolize alcohol into acetaldehyde at a much faster rate. That variant is more common in East Asian populations and has also shown a protective effect in European-American samples. Zhou’s cross-ancestry analysis identified two independent ADH1B missense variants in its African-ancestry meta-analysis.

Carriers of ALDH2*2 metabolize acetaldehyde at a much slower rate, and that variant appears only in East Asian populations. Acetaldehyde accumulates, producing flushing, tachycardia and nausea. Roughly 36 percent of Japanese, Chinese and Korean people show that response, and around 540 million people worldwide carry ALDH2 deficiency, about 8 percent of the global population.

Combined, the two variants prove highly protective against developing alcohol use disorder, and the mechanism is simple deterrence: drinking feels bad, so less drinking happens. That protection carries a serious trade-off.

Does the Alcohol Flush Reaction Protect You?

The alcohol flush reaction protects against alcohol use disorder and raises cancer risk substantially in the people who carry one copy of the variant and drink anyway. Whether a person carries one copy or two decides which outcome applies.

Per Brooks and colleagues in PLoS Medicine, ALDH2 Lys/Lys homozygotes cannot consume significant amounts of alcohol and are therefore protected against the increased esophageal cancer risk that comes with drinking. Heterozygotes are the group at risk: case-control studies in Japan and Taiwan found odds ratios for esophageal squamous cell carcinoma ranging from 3.7 to 18.1 among low-activity ALDH2 heterozygotes who drink, and prospective data put the relative hazard for future upper aerodigestive tract cancers at approximately 12 times that of people with active ALDH2.

Acetaldehyde explains the mechanism. Acetaldehyde is a mutagen and animal carcinogen that causes DNA damage, and ALDH2-deficient people sustain higher levels of acetaldehyde-related DNA and chromosomal damage than people with fully active ALDH2 at equivalent alcohol intake. Flushing after drinking is a signal worth taking seriously rather than a quirk to drink through. Family history carries a separate and smaller effect.

How Much Does Family History Raise the Risk?

One affected parent roughly doubles the odds of developing alcohol use disorder. In the Copenhagen Perinatal Cohort, 7,177 people born in 1959 to 1961 were followed to around age 45, and 466 of them, or 6.5 percent, developed alcohol use disorder.

Maternal alcohol use disorder carried an odds ratio of 1.96 and paternal alcohol use disorder an odds ratio of 1.99 in that cohort. Risk rises with the density of family history rather than with the bare fact of it: in prospective work on multiplex families, meaning families with several affected relatives, offspring carried an odds ratio of 3.63 for developing alcohol abuse or dependence.

Twin data supports the same picture. In the Australian Twin Registry, heritability of alcohol dependence ran 53 percent against 36 percent for the timing of a first drink, and monozygotic concordance in males ran 56 percent against 33 percent for dizygotic twins. Environment decides how far that genetic risk travels.

How Do Genes and Environment Interact?

Genetic risk for alcohol use disorder operates conditionally on environment. Per NIAAA, the central concept of genotype-by-environment interaction is conditionality: understanding how genes act requires taking the environment into account, and understanding the environment requires taking the genes into account.

Two documented moderators are lower parental monitoring and the presence of substance-using friends, both of which amplify genetic influences on adolescent substance use.

Japanese data gives the clearest demonstration available. The proportion of people with alcohol dependence carrying one copy of the protective ALDH2*2 allele rose from 2.5 percent in 1979 to 8.0 percent in 1986 and 13.1 percent in 1992. The gene did not change across those 13 years. The drinking environment changed, and a protective genotype stopped constituting sufficient protection.

Age of first drink is the other well-quantified factor. Grant and Dawson’s analysis of 27,616 drinkers in the 1992 National Longitudinal Alcohol Epidemiologic Survey found rates of lifetime DSM-IV alcohol dependence falling from more than 40 percent among people who started drinking at 14 or younger to roughly 10 percent among those who started at 20 or older, with the odds decreasing 14 percent for each additional year of onset age. Those are DSM-IV dependence figures, which the DSM-5-TR now subsumes within alcohol use disorder.

Genetics and timing are not independent. The Australian twin data found a genetic correlation of 0.59 between timing of first alcohol use and alcohol dependence, meaning much of the link between early drinking and later dependence runs through shared genetic influences rather than through the early drinking itself. None of this yields a usable test.

Can a Genetic Test Tell You Your Risk?

No genetic test predicts alcohol use disorder risk usefully today, because polygenic risk scores explain roughly 2.5 to 3.5 percent of variance. Barr and colleagues concluded that such scores are unlikely to prove useful for substance use disorders in a clinical setting.

People in the top 5 percent of polygenic score proved around twice as likely to develop alcohol use disorder as the remaining 95 percent, which is not a clinically actionable figure. Family history remains the more useful signal, and family history costs nothing. Two beliefs about inherited risk cause the most unnecessary alarm.

Which Beliefs About Inherited Risk Are Wrong?

Two widely repeated claims about the heritability of alcohol use disorder fail against the primary sources, and both overstate how much a family history settles.

Common misconception	What the evidence shows
“Children of parents with alcohol use disorder are four times more likely to develop it.”	The best registry-cohort figure for a single affected parent is roughly a doubling: odds ratios of 1.96 maternal and 1.99 paternal in the Copenhagen Perinatal Cohort of 7,177 people. The 3.63 odds ratio applies to multiplex families carrying several affected relatives, not to one affected parent.
“There is a gene for alcoholism.”	Alcohol use disorder is polygenic. Zhou and colleagues identified 110 independent risk variants across 1,079,947 people, and per NIAAA most contributing genes make only very small contributions to overall risk.

Both corrections point the same way: genetic risk shifts the odds and settles nothing.

What Does This Mean If Alcohol Use Disorder Runs in Your Family?

Genetic risk changes the odds and decides nothing, because roughly half the population-level variation traces to environment, timing and circumstance. The gene-environment evidence shows that the environmental half is where the leverage sits.

Three things follow practically. Later first drinking lowers risk substantially, at 14 percent per additional year of onset age. High alcohol tolerance reflects nervous system adaptation rather than protection, and high tolerance raises withdrawal risk. And a family history is worth naming to a clinician, because a family history changes how drinking gets assessed rather than how it gets judged.

Anyone reconsidering their drinking asks how long alcohol stays in your system first.

The second question is what happens when you stop drinking, and the answer runs across a staged timeline rather than a single event.

Where Can Families Get Help in Los Angeles?

New Spirit Recovery provides medically monitored alcohol detox and residential treatment at its Tarzana, Northridge and Encino locations, with family programming running throughout treatment. Alcohol use disorder clusters in families, so the family forms part of the clinical picture.

Family therapy and education continues alongside the individual work rather than as a single family day.

The admissions and intake process brings the family into the assessment from the start.

Crisis resources. Confusion, fever or a seizure during alcohol withdrawal is a medical emergency: call 911. The 988 Suicide and Crisis Lifeline answers three ways: call 988, text 988, or chat at 988lifeline.org/chat. Spanish-language support answers by pressing 2, and the Lifeline’s videophone option serves ASL users.

“A family history changes how we assess someone rather than what we conclude about them. It tells us where to look and what to ask, and it settles nothing on its own.” Dr. Patrick Lockwood, Psy.D., Clinical Consultant at New Spirit Recovery.

Frequently Asked Questions

Is alcoholism hereditary?

Alcohol use disorder, the DSM-5-TR term, is approximately 50 percent heritable, with the best meta-analytic estimate at 0.49 and a 95 percent confidence interval of 0.43 to 0.53. Heritability describes population variance rather than an individual’s chance of developing it.

Is there a gene for alcoholism?

No. Alcohol use disorder is polygenic. The largest study, covering 1,079,947 people, identified 110 independent risk variants, and per NIAAA most contributing genes make only very small contributions to overall risk.

If my parent had alcohol use disorder, will I get it?

Not necessarily. One affected parent roughly doubles the odds, at 1.96 for maternal and 1.99 for paternal alcohol use disorder in a Danish cohort where 6.5 percent of the whole group developed it. Families with several affected relatives carry higher odds, around 3.63.

Does the alcohol flush reaction mean I cannot become dependent?

The ALDH2*2 variant is protective and the protection is not absolute. Among people with alcohol dependence in Japan, carriers of one copy rose from 2.5 percent in 1979 to 13.1 percent in 1992 as the drinking environment changed. Heterozygotes who drink also carry substantially raised upper aerodigestive cancer risk.

Can I get a genetic test for alcohol use disorder risk?

No test proves clinically useful today. Polygenic risk scores explain around 2.5 to 3.5 percent of variance in alcohol use disorder, and researchers conclude such scores are unlikely to prove useful clinically for substance use disorders.

Does starting to drink young raise the risk?

Yes. Rates of lifetime DSM-IV alcohol dependence fell from more than 40 percent among people who began drinking at 14 or younger to roughly 10 percent among those who began at 20 or older, with odds decreasing 14 percent per additional year of onset age.

References

1. Verhulst, B., Neale, M. C., Kendler, K. S. (2015). The heritability of alcohol use disorders: a meta-analysis of twin and adoption studies. Psychological Medicine, 45(5), 1061-1072.
2. National Institute on Alcohol Abuse and Alcoholism. Genetics and Alcohol Use Disorder; and Alcohol Research: Current Reviews on genotype-by-environment interaction.
3. Zhou, H., et al. (2023). Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. Nature Medicine.
4. Brooks, P. J., Enoch, M. A., Goldman, D., Li, T. K., Yokoyama, A. (2009). The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Medicine, 6(3), e50.
5. Grant, B. F., Dawson, D. A. (1997). Age at onset of alcohol use and its association with DSM-IV alcohol abuse and dependence. Journal of Substance Abuse, 9, 103-110.
6. Sartor, C. E., et al. (2009). Common genetic influences on the timing of first use and DSM-IV alcohol dependence. Addiction.
7. Barr, P. B., et al. (2020). Using polygenic scores for identifying individuals at increased risk of substance use disorders in clinical and population samples. Translational Psychiatry, 10, 196.
8. Visscher, P. M., Hill, W. G., Wray, N. R. (2008). Heritability in the genomics era: concepts and misconceptions. Nature Reviews Genetics, 9(4), 255-266.
9. American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.).